Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness.
about
Prodrug Strategies for PaclitaxelNanoparticle-mediated drug delivery for treating melanomaPhototriggerable 2',7-caged paclitaxelStabilization of resveratrol in blood circulation by conjugation to mPEG and mPEG-PLA polymers: investigation of conjugate linker and polymer composition on stability, metabolism, antioxidant activity and pharmacokinetic profileA polymeric prodrug of 5-fluorouracil-1-acetic acid using a multi-hydroxyl polyethylene glycol derivative as the drug carrierPoly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel deliveryStimuli-responsive star poly(ethylene glycol) drug conjugates for improved intracellular delivery of the drug in neuroinflammationBioactive factor delivery strategies from engineered polymer hydrogels for therapeutic medicine.Thermoresponsive aggregation behavior of triterpene-poly(ethylene oxide) conjugates in water.Increased cardiac distribution of mono-PEGylated Radix Ophiopogonis polysaccharide in both myocardial infarction and ischemia/reperfusion rats.From stealthy polymersomes and filomicelles to "self" Peptide-nanoparticles for cancer therapyLong-circulating delivery of bioactive polysaccharide from radix ophiopogonis by PEGylationCan formulation and drug delivery reduce attrition during drug discovery and development-review of feasibility, benefits and challenges.Designing Paclitaxel drug delivery systems aimed at improved patient outcomes: current status and challenges.Pharmacokinetic consequences of pegylation.Improved biochemical strategies for targeted delivery of taxoidsAnticancer carrier-linked prodrugs in clinical trials.Design, synthesis and applications of hyaluronic acid-paclitaxel bioconjugates.Chemo-enzymatic Synthesis of Propionyl-ester-linked Taxol-monosaccharide Conjugate and its Drug Delivery System Using Hybrid-Bio-nanocapsules Targeting Brain Glioma Cells.Macromolecules as taxane delivery systems.Synthesis and In Vitro Evaluation of Polyethylene Glycol-Paclitaxel Conjugates for Lung Cancer Therapy.Advances in oral delivery of anti-cancer prodrugs.Anticancer and immunostimulatory activity by conjugate of paclitaxel and non-toxic derivative of LPS for combined chemo-immunotherapy.Synthesis and anti-cancer efficacy of rapid hydrolysed water-soluble paclitaxel pro-drugs.Chemo-enzymatic synthesis of ester-linked 2-phenylindole-3-carboxaldehyde-monosaccharide conjugate as potential prodrug.Chemo-enzymatic synthesis of glycolyl-ester-linked taxol-monosaccharide conjugate and its drug delivery system using hepatitis B virus envelope L bio-nanocapsules.Towards potential nanoparticle contrast agents: Synthesis of new functionalized PEG bisphosphonates.Haloperidol-associated stealth liposomes: a potent carrier for delivering genes to human breast cancer cells.Release behavior of amoxicillin from glycol chitosan superporous hydrogels.Drug delivery for bioactive polysaccharides to improve their drug-like properties and curative efficacy.Water-soluble and amphiphilic phospholipid copolymers having 2-methacryloyloxyethyl phosphorylcholine units for the solubilization of bioactive compounds.Delivery of radix ophiopogonis polysaccharide via sucrose acetateisobutyrate-based in situ forming systems alone or combined with itsmono-PEGylation.Controlled release of paclitaxel from biodegradable unsaturated poly(ester amide)s/poly(ethylene glycol) diacrylate hydrogels.
P2860
Q26745997-FA0C1AED-B516-4F04-800A-C42F33392215Q26798379-1EB25129-6F9A-4424-97F9-5CE85C67A1FFQ27322829-9746AEC9-F167-4AA5-936A-0D23C3DC0BF1Q28544851-BD092E9A-EBBD-450E-AFBB-9102F9ADA6EBQ28544909-62033FB6-E93B-442C-B2F6-29A8FA0A5E26Q30664584-6610DF96-A1F5-4595-BECC-A9F59609F470Q33708080-D862F917-9ADB-48DE-B1FE-147C751C95DBQ34204037-2FD61E36-126A-404C-8109-7CC29A40A010Q34377712-5EA14E73-6681-4951-8D78-2296D0631B1AQ34982390-06C8F235-0B36-48E6-8419-7931833A6CBAQ35295381-CC369245-E450-4BF7-8492-482AF7A8E991Q35574701-15DC0585-C2F6-4BD6-AB66-AA2CAC7DC45EQ36111924-B4B5F379-B3CF-4748-ABD4-C6EE4ECC479DQ36183605-028ED8D7-6FBF-486C-B1A5-E0A42B77EC8BQ36604526-E85BE41C-70F0-43E6-84B6-D82385184AE5Q36642502-B9E6EA05-D26E-4AE1-9A37-5FCA37DBDBE3Q36861603-CC7B1E36-EC2C-4742-ACCA-C7F9F07CD1F6Q37096500-F7F4DC5D-2132-45DF-B2D3-2A5734F7806CQ37615077-4C893CB9-28EE-438D-BB8E-D78A9D7FD130Q37818236-015C171E-0BA7-4029-A0C1-A3BE76B14256Q38785747-E0ED3E66-CED9-4F53-B8E3-C29BBE9597DEQ38862820-8E58421E-A28E-48EF-BE9B-6FE0F195676FQ39356108-D90847A5-0860-4B3C-8A76-539C09BAB487Q40005029-DBB8A28E-9763-45DF-BBC3-EB1DC6F5F34CQ41957172-D9706705-AA14-40B1-B5A3-430D23594211Q42065655-51B85D9E-2176-47BC-8CA0-34EB3C1B80EFQ42367406-C4235FE0-8F0A-48E9-9604-6597A41DD881Q45253860-4731CF90-8884-47F8-8E52-396D7E41AB93Q46073376-72829316-B1B1-455E-8594-484B76E4A072Q47362437-02A6FEE2-E40D-4F65-8847-71441B03C4BBQ47691391-E31E2B2F-7BC8-4742-A53E-2DB3E8594256Q50044609-9E0705A4-37A0-4FDC-BA93-4342906FEAFFQ50986911-9574F94D-0D93-4653-8599-3DF67155D640
P2860
Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Drug delivery systems: water s ...... ign and in vivo effectiveness.
@ast
Drug delivery systems: water s ...... ign and in vivo effectiveness.
@en
type
label
Drug delivery systems: water s ...... ign and in vivo effectiveness.
@ast
Drug delivery systems: water s ...... ign and in vivo effectiveness.
@en
prefLabel
Drug delivery systems: water s ...... ign and in vivo effectiveness.
@ast
Drug delivery systems: water s ...... ign and in vivo effectiveness.
@en
P2093
P356
P1476
Drug delivery systems: water s ...... ign and in vivo effectiveness.
@en
P2093
P304
P356
10.1021/JM950475E
P407
P577
1996-01-01T00:00:00Z